UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000020762
Receipt No. R000023964
Official scientific title of the study Assessment of the atrial fibrillation ablation outcome
Date of disclosure of the study information 2016/04/01
Last modified on 2017/03/03 (Ver. 7)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Assessment of the atrial fibrillation ablation outcome
Title of the study (Brief title) Assessment of the atrial fibrillation ablation outcome
Region
Japan

Condition
Condition atrial fibrillation
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The outcome of atrial fibrillation catheter ablation was assessed by utilizing 24-hour Holter ECG and telemonitoring ECG.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Relapse of atrial fibrillation after catheter ablation
The post operative 6-month monitoring using Holter ECG and telemonitoring ECG
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Device,equipment
Interventions/Control_1 monthly Holter ECG, telemonitoring ECG twice daily
During the postoperative 6 months
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit
75 years-old >
Gender Male and Female
Key inclusion criteria Candidates for catheter ablation of atrial fibrillation
Key exclusion criteria Contraindiation for catheter ablation of atrial fibrillation
Target sample size 31

Research contact person
Name of lead principal investigator Seiji Takatsuki
Organization Keio University School of Medicine
Division name Department of Cardiology
Address 35 Shinanomachi Shinjuku-ku
TEL 0333531211
Email seiji.takatsuki@gmail.com

Public contact
Name of contact person Takehiro Kimura
Organization Keio University School of Medicine
Division name Department of Cardiology
Address 35 Shinanomachi Shinjuku-ku
TEL 0333531211
Homepage URL
Email kimura@z7.keio.jp

Sponsor
Institute Keio University School of Medicine
Institute
Department

Funding Source
Organization Keio University School of Medicine
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 04 Month 01 Day

Progress
Recruitment status Main results already published
Date of protocol fixation
2013 Year 06 Month 24 Day
Anticipated trial start date
2013 Year 07 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results http://www.ncbi.nlm.nih.gov/pubmed/27385021
Results
Other related information

Management information
Registered date
2016 Year 01 Month 27 Day
Last modified on
2017 Year 03 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023964